Navigation Links
Low-Dose Steroids Reduce Joint Damage From Rheumatoid Arthritis

s of glucocorticoid pills along with so-called disease-modifying drugs for one to two years. Periodic X-rays revealed the extent of joint erosion and other signs of damage.

All studies except one showed reduced progression of joint damage in patients taking glucocorticoids. When reviewers used statistical methods to focus on only the highest-quality data, the benefits remained statistically significant.

“Even in the most conservative estimate, the evidence that glucocorticoids given in addition to standard therapy can substantially reduce the rate of erosion progression in rheumatoid arthritis is convincing,” they say.

The authors say, however, that minimization of joint damage seen on X-rays may not equate to noticeable improvements for patients: “It does not necessarily follow that patients will gain long-term functional benefit.” However, two related studies, including one by Kirwan, suggest “an important link” between the two.

Because of the known health risks associated with intensive steroid use, concern persists regarding long-term use at any level. The authors cite a 2006 systematic review covering the adverse effects of low-dose glucocorticoids, which concluded that “few of the commonly held beliefs about their incidence, prevalence and impact are supported by clear scientific evidence.”

Moreover, safety data from recent randomized controlled clinical trials of low-dose steroids for RA suggest that negative side effects are “modest” and similar to those of sham treatments, say Kirwan and colleagues. Additionally, the most immediate concern — reduced bone mineral density — can now be readily treated.

Nevertheless, potential adverse reactions to glucocorticoid therapy merit further research, say the authors, as does usefulness of steroid treatment for patients who have had rheumatoid arthritis for 3 years or more.

Zashin urges patients recently diagnosed with rheumatoid art
'"/>




Page: 1 2 3

Related medicine news :

1. Low-Dose Hormones Help the Bones
2. Low-Dose Oral Contraceptives May Increase Risk For Heart Attack Or Stroke
3. FDA To Reconsider Standards for Reviewing Low-Dose Oral Contraceptives
4. Inhaled Steroids Safe & Effective for Children with Asthma
5. The Use Of Steroids for Dizziness Questioned
6. The Use Of Oral Steroids For Muscular Dystrophy Questioned
7. No Steroids for Traumatic Brain Injury
8. Steroids Effective For Treating Carpel Tunnel Syndrome
9. The Use Of Steroids After Liver Transplants Questioned
10. New Study Will The Look Into The Effects Of Synthetic Steroids
11. Abuse Of Anabolic Steroids Causes Acne In Bodybuilders
Post Your Comments:
(Date:5/23/2012)... second edition of Law and the American Health Care ... 2012. Building on its 1997 predecessor, the second edition ... intersection of law and the U.S. health care system. ... a time of unprecedented change in how health care ... of study, the book focuses on how a dramatically ...
(Date:5/23/2012)... of the same kind, thereby triggering skeletal and cardiac ... from the RUB Heart and Diabetes Center NRW in ... an interdisciplinary research project with colleagues from the universities ... Journal of Biological Chemistry . , One ... stabilizing filaments inside of the cells. Different mutations in ...
(Date:5/23/2012)... FRANCISCO The number of viral infections during infancy ... to a new study from researchers in the Netherlands. ... later in childhood, this association was due in part ... in infancy, particularly rhinovirus, are thought to be a ... unclear whether this association is due to the viruses ...
(Date:5/23/2012)... present findings on prostate cancer risk, screening, treatment ... of the American Urological Association May 19-23 in ... to provide expert comment for reporters covering the ... presented and their embargo dates include: , ... surgery hormone therapy , Embargoed until 10:30 a.m. ...
(Date:5/22/2012)... MAYWOOD, Ill. -- Children born with cleft lip, ... medical challenges beyond appearance. , Patients can face ... well as social and psychological challenges, Laura Swibel ... colleagues write in the June 2012 issue of ... "The management of patients with craniofacial syndromes is ...
Breaking Medicine News(10 mins):Health News:Landmark textbook on health care and the US legal system released 2Health News:Aggregating instead of stabilizing: New insights into the mechanisms of heart disease 2Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4Health News:Cleft lip/palate cause much more than cosmetic problems 2
... across the world have breast implants done for augmentation purposes ... direction, eminent plastic surgeons// have united to offer services in ... comes at an economical rate compared to the so called ... life. The doctors involved are all a highly creditable force ...
... van der Lely, director of the Centre for Developmental ... has developed// a test to identify dyslexia. ,Called ... a range of language disorders, including dyslexia, by assessing ... a million children suffer from a language problem and ...
... University of Adelaide in the Discipline of Pharmacology have ... of heroin addicts around// the world. They have ... dosage levels for heroin addicts. ,The study ... effective in distributing drugs throughout their body to the ...
... outbreak in the Sydney CBD is linked to the Royal ... suspect//. However, they could not confirm the link. ... bacteria belonging to the Legionella family, Legionella pneumophilia, have been ... in the Circular Quay area on New Year's Eve. ...
... of Oxford have discovered a unique way to switch off ... form of RNA, a chemical found in cell nuclei, whose ... exploring this area and its role in offsetting the development ... direct role in the synthesis of proteins, the building blocks ...
... researchers from the February issue of the American Naturalist ... more likely// to eat their offspring when they have ... ,"The most drastic decision a father can make is ... candidate at Simon Fraser University), Lawrence Dill (Simon Fraser ...
Other Medicine News:Health News:Genetic-Key to Stop Heroin Addicts 2Health News:Role of RNA in Checking the Development of Tumors 2
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... new blood test may make it,easier for ... dosing for patients undergoing continuous infusion chemotherapy,regimens. ... a nanoparticle-based,immunoassay from Saladax Biomedical, called 5-FU ... high performance liquid,chromatography (HPLC) or LC-MS/MS, but ...
... ANGELES, June 23 Canopus BioPharma, Inc.,(OTC: CBIA), ... Medicines,Control Council has granted approval for a Phase ... effect of CB1400 on the,gastrointestional tract from radiation-induced ... in the development of CB1400 as a novel,preventative, ...
Other Medicine Technology:New Data Demonstrates 5-FU Personalized Chemotherapy Management (PCM(R)) Assay Provides Similar Performance to More Complicated Liquid Chromatography-Mass Spectrometry (LC-MS/MS) 2New Data Demonstrates 5-FU Personalized Chemotherapy Management (PCM(R)) Assay Provides Similar Performance to More Complicated Liquid Chromatography-Mass Spectrometry (LC-MS/MS) 3New Data Demonstrates 5-FU Personalized Chemotherapy Management (PCM(R)) Assay Provides Similar Performance to More Complicated Liquid Chromatography-Mass Spectrometry (LC-MS/MS) 4CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck 2
... SPECIFICATIONS Form: Granular, free-flowing powder EEO (-m r ... 1.5C Remelt Point (1.5%): 88.0 1.5C ... 1,200 gm/cm 2 Gel Strength (1.5%): greater ... Moisture: less than or equal to 7% Turbidity ...
... ≤ 5000 mg/kg sulfate (SO 4 ) ≤ 5000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 ... K ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
... Application: Forms strong flexible gels ... ID clarifier: mixture of wide ... Solubility: water 10 mg/mL, clear, ... for molecular biology MP: 90 ...
Inquire...
Medicine Products: